Determinants of vaccine immunogenicity in HIV-infected pregnant women: Analysis of B and T cell responses to pandemic H1N1 monovalent vaccine

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Weinberg, Adriana ^a   Muresan, Petronella ^b   Richardson, Kelly M ^a   Fenton, Terence ^b   Dominguez, Teresa ^a   Bloom, Anthony ^c   Watts, D Heather ^d,f   Abzug, Mark J ^a   Nachman, Sharon A ^e   Levin, Myron J ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e STONY BROOK UNIVERSITY   (United States)

^f U S DEPARTMENT OF STATE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; GAMMA INTERFERON; GRANZYME B; HLA DR ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA VACCINE; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; VIRUS ANTIBODY; VIRUS RNA;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ASSAY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; MOLECULAR DYNAMICS; NONHUMAN; PANDEMIC INFLUENZA; PREGNANCY; PREGNANT WOMAN; SEASONAL INFLUENZA; VACCINATION; VIRUS IDENTIFICATION; ADULT; COMPLICATION; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H1N1); LYMPHOCYTE ACTIVATION; MALE; PATHOGENICITY; PATHOLOGY; PREGNANCY COMPLICATIONS, INFECTIOUS; T LYMPHOCYTE SUBPOPULATION;

ERAGROSTIS TEF;

ADULT; ANTIBODIES, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LYMPHOCYTE ACTIVATION; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; T-LYMPHOCYTE SUBSETS;

EID: 84928910477     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122431     Document Type: Article

References (87)

1. Dolan GP, Myles PR, Brett SJ, Enstone JE, Read RC, Openshaw PJ, et al. The comparative clinical course of pregnant and non-pregnant women hospitalised with influenza A(H1N1)pdm09 infection. PloS one. 2012; 7:e41638. PMID: 22870239
2. Dubar G, Azria E, Tesniere A, Dupont H, Le Ray C, Baugnon T, et al. French experience of 2009 A/H1N1v influenza in pregnant women. PloS one. 2010; 5.
3. Hewagama S, Walker SP, Stuart RL, Gordon C, Johnson PD, Friedman ND, et al. 2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2010; 50:686-90. doi: 10.1086/650460 PMID: 20100064
4. Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. The New England journal of medicine. 2010; 362:27-35. doi: 10.1056/NEJMoa0910444 PMID: 20032319
5. Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA: the journal of the American Medical Association. 2010; 303:1517-25. doi: 10.1001/jama.2010.479 PMID: 20407061
6. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. American journal of epidemiology. 1998; 148:1094-102. PMID: 9850132
7. Cox S, Posner SF, McPheeters M, Jamieson DJ, Kourtis AP, Meikle S. Hospitalizations with respiratory illness among pregnant women during influenza season. Obstetrics and gynecology. 2006; 107:1315-22. PMID: 16738158
8. Stanwell-Smith R, Parker AM, Chakraverty P, Soltanpoor N, Simpson CN. Possible association of influenza A with fetal loss: investigation of a cluster of spontaneous abortions and stillbirths. Communicable disease report CDR review. 1994; 4:R28-32. PMID: 7513232
9. Fukushima W, Ohfuji S, Deguchi M, Kawabata K, Hatayama H, Yoshida H, et al. Effectiveness of an influenza A (H1N1) 2009 monovalent vaccine among Japanese pregnant women: a prospective observational study assessing antibody efficacy. Vaccine. 2012; 30:7630-6. doi: 10.1016/j.vaccine.2012.10.027 PMID: 23085364
10. Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, et al. Effectiveness of maternal influenza immunization in mothers and infants. The New England journal of medicine. 2008; 359:1555-64. doi: 10.1056/NEJMoa0708630 PMID: 18799552
11. Adedinsewo DA, Noory L, Bednarczyk RA, Steinhoff MC, Davis R, Ogbuanu C, et al. Impact of maternal characteristics on the effect of maternal influenza vaccination on fetal outcomes. Vaccine. 2013; 31:5827-33. doi: 10.1016/j.vaccine.2013.09.071 PMID: 24120677
12. Benowitz I, Esposito DB, Gracey KD, Shapiro ED, Vazquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2010; 51:1355-61. doi: 10.1086/657309 PMID: 21058908
13. Eick AA, Uyeki TM, Klimov A, Hall H, Reid R, Santosham M, et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Archives of pediatrics & adolescent medicine. 2011; 165:104-11.
14. Maltezou HC, Fotiou A, Antonakopoulos N, Kallogriopoulou C, Katerelos P, Dimopoulou A, et al. Impact of postpartum influenza vaccination of mothers and household contacts in preventing febrile episodes, influenza-like illness, healthcare seeking, and administration of antibiotics in young infants during the 2012-2013 influenza season. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2013; 57:1520-6.
15. Omer SB, Goodman D, Steinhoff MC, Rochat R, Klugman KP, Stoll BJ, et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS medicine. 2011; 8:e1000441. doi: 10.1371/journal.pmed.1000441 PMID: 21655318
16. Omer SB, Zaman K, Roy E, Arifeen SE, Raqib R, Noory L, et al. Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: results from a randomized, blinded, controlled trial. The Journal of infectious diseases. 2013; 207:1144-7. doi: 10.1093/infdis/jit003 PMID: 23300160
17. Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. The Journal of infectious diseases. 1993; 168:647-56. PMID: 8354906
18. Bischoff AL, Folsgaard NV, Carson CG, Stokholm J, Pedersen L, Holmberg M, et al. Altered response to A(H1N1)pnd09 vaccination in pregnant women: a single blinded randomized controlled trial. PloS one. 2013; 8:e56700. doi: 10.1371/journal.pone.0056700 PMID: 23637733
19. Schlaudecker EP, McNeal MM, Dodd CN, Ranz JB, Steinhoff MC. Pregnancy modifies the antibody response to trivalent influenza immunization. The Journal of infectious diseases. 2012; 206:1670-3. doi: 10.1093/infdis/jis592 PMID: 22984116
20. Cohen C, Simonsen L, Sample J, Kang JW, Miller M, Madhi SA, et al. Influenza-related mortality among adults aged 25-54 years with AIDS in South Africa and the United States of America. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2012; 55:996-1003.
21. Fine AD, Bridges CB, De Guzman AM, Glover L, Zeller B, Wong SJ, et al. Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2001; 32:1784-91.
22. Klein MB, Lu Y, DelBalso L, Cote S, Boivin G. Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2007; 45:234-40.
23. Madhi SA, Kuwanda L, Venter M, Violari A. Prospective cohort study comparing seasonal and H1N1 (2009) pandemic influenza virus illnesses in HIV-infected children during 2009. The Pediatric infectious disease journal. 2014; 33:174-6. doi: 10.1097/INF.0b013e3182a73ebb PMID: 23907261
24. Martinez E, Marcos MA, Hoyo-Ulloa I, Anton A, Sanchez M, Vilella A, et al. Influenza A H1N1 in HIV-infected adults. HIV medicine. 2011; 12:236-45. doi: 10.1111/j.1468-1293.2010.00905.x PMID: 21255221
25. Noguera-Julian A, Provens AC, Soler-Palacin P, Espiau M, Mur A, Mendez M, et al. Pandemic influenza a (2009 H1N1) in human immunodeficiency virus-infected catalan children. The Pediatric infectious disease journal. 2011; 30:173-5. doi: 10.1097/INF.0b013e3181f5358b PMID: 20802374
26. Peters PJ, Skarbinski J, Louie JK, Jain S, Roland M, Jani SG, et al. HIV-infected hospitalized patients with 2009 pandemic influenza A (pH1N1) - United States, spring and summer 2009. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2011; 52 Suppl 1:S183-8.
27. Richardson K, Weinberg A. Reduced immunogenicity of influenza vaccines in HIV-infected compared with uninfected pregnant women is associated with regulatory T cells. AIDS. 2011; 25:595-602. doi: 10.1097/QAD.0b013e32834411a8 PMID: 21368590
28. Chadwick EG, Chang G, Decker MD, Yogev R, Dimichele D, Edwards KM. Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. The Pediatric infectious disease journal. 1994; 13:206-11. PMID: 8177629
29. Kroon FP, van Dissel JT, de Jong JC, van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS. 1994; 8:469-76. PMID: 7912086
30. Miotti PG, Nelson KE, Dallabetta GA, Farzadegan H, Margolick J, Clements ML. The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA: the journal of the American Medical Association. 1989; 262:779-83.
31. Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmood K, Reisinger K, et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis. 2000; 181:1133-7. PMID: 10720541
32. Levin MJ, Song LY, Fenton T, Nachman S, Patterson J, Walker R, et al. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Vaccine. 2008; 26:4210-7. doi: 10.1016/j.vaccine.2008.05.054 PMID: 18597900
33. Vigano A, Zuccotti GV, Pacei M, Erba P, Castelletti E, Giacomet V, et al. Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy. J Acquir Immune Defic Syndr. 2008; 48:289-96. doi: 10.1097/QAI.0b013e3181632cda PMID: 18545155
34. Benne CA, Kroon FP, Harmsen M, Tavares L, Kraaijeveld CA, De Jong JC. Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals. Clinical and diagnostic laboratory immunology. 1998; 5:114-7. PMID: 9455891
35. Flynn PM, Nachman S, Muresan P, Fenton T, Spector SA, Cunningham CK, et al. Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults. The Journal of infectious diseases. 2012; 206:421-30. doi: 10.1093/infdis/jis360 PMID: 22615311
36. Fuller JD, Craven DE, Steger KA, Cox N, Heeren TC, Chernoff D. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 1999; 28:541-7.
37. Weinberg A, Song LY, Walker R, Allende M, Fenton T, Patterson-Bartlett J, et al. Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children. Journal of acquired immune deficiency syndromes. 2010; 55:189-96. doi: 10.1097/QAI.0b013e3181e46308 PMID: 20581690
38. Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. The Journal of hygiene. 1972; 70:767-77. PMID: 4509641
39. Black S, Nicolay U, Vesikari T, Knuf M, Del Giudice G, Della Cioppa G, et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. The Pediatric infectious disease journal. 2011; 30:1081-5. doi: 10.1097/INF.0b013e3182367662 PMID: 21983214
40. Pedersen GK, Madhun AS, Breakwell L, Hoschler K, Sjursen H, Pathirana RD, et al. T-helper 1 cells elicited by H5N1 vaccination predict seroprotection. The Journal of infectious diseases. 2012; 206:158-66. doi: 10.1093/infdis/jis330 PMID: 22551811
41. Eto D, Lao C, DiToro D, Barnett B, Escobar TC, Kageyama R, et al. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PloS one. 2011; 6:e17739. doi: 10.1371/journal.pone.0017739 PMID: 21423809
42. Cubas RA, Mudd JC, Savoye AL, Perreau M, van Grevenynghe J, Metcalf T, et al. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nature medicine. 2013; 19:494-9. doi: 10.1038/nm.3109 PMID: 23475201
43. Pallikkuth S, Parmigiani A, Silva SY, George VK, Fischl M, Pahwa R, et al. Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine. Blood. 2012; 120:985-93. doi: 10.1182/blood-2011-12-396648 PMID: 22692510
44. Pallikkuth S, Pilakka Kanthikeel S, Silva SY, Fischl M, Pahwa R, Pahwa S. Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy. Journal of immunology. 2011; 186:6173-81. doi: 10.4049/jimmunol.1100264 PMID: 21531891
45. Moir S, Fauci AS. B cells in HIV infection and disease. Nature reviews Immunology. 2009; 9:235-45. doi: 10.1038/nri2524 PMID: 19319142
46. Imbeault M, Ouellet M, Giguere K, Bertin J, Belanger D, Martin G, et al. Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment. Journal of virology. 2011; 85:2189-200. doi: 10.1128/JVI.01993-10 PMID: 21177803
47. Martin G, Roy J, Barat C, Ouellet M, Gilbert C, Tremblay MJ. Human immunodeficiency virus type 1-associated CD40 ligand transactivates B lymphocytes and promotes infection of CD4+ T cells. Journal of virology. 2007; 81:5872-81. PMID: 17392362
48. Moir S, Malaspina A, Pickeral OK, Donoghue ET, Vasquez J, Miller NJ, et al. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. The Journal of experimental medicine. 2004; 200:587-99. PMID: 15508184
49. Perise-Barrios AJ, Munoz-Fernandez MA, Pion M. Direct phenotypical and functional dysregulation of primary human B cells by human immunodeficiency virus (HIV) type 1 in vitro. PloS one. 2012; 7:e39472. doi: 10.1371/journal.pone.0039472 PMID: 22768302
50. Qiao X, He B, Chiu A, Knowles DM, Chadburn A, Cerutti A. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nature immunology. 2006; 7:302-10. PMID: 16429138
51. Viau M, Veas F, Zouali M. Direct impact of inactivated HIV-1 virions on B lymphocyte subsets. Molecular immunology. 2007; 44:2124-34. PMID: 17134757
52. Rappocciolo G, Piazza P, Fuller CL, Reinhart TA, Watkins SC, Rowe DT, et al. DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes. PLoS pathogens. 2006; 2:e70. PMID: 16839201
53. Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O'Shea MA, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. The Journal of experimental medicine. 2008; 205:1797-805. doi: 10.1084/jem.20072683 PMID: 18625747
54. Pensieroso S, Galli L, Nozza S, Ruffin N, Castagna A, Tambussi G, et al. B-cell subset alterations and correlated factors in HIV-1 infection. AIDS. 2013; 27:1209-17. doi: 10.1097/QAD.0b013e32835edc47 PMID: 23343911
55. Titanji K, De Milito A, Cagigi A, Thorstensson R, Grutzmeier S, Atlas A, et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood. 2006; 108:1580-7. PMID: 16645169
56. Fontaine J, Chagnon-Choquet J, Valcke HS, Poudrier J, Roger M. High expression levels of B lymphocyte stimulator (BLyS) by dendritic cells correlate with HIV-related B-cell disease progression in humans. Blood. 2011; 117:145-55. doi: 10.1182/blood-2010-08-301887 PMID: 20870901
57. Hart M, Steel A, Clark SA, Moyle G, Nelson M, Henderson DC, et al. Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. Journal of immunology. 2007; 178:8212-20. PMID: 17548660
58. Ho J, Moir S, Malaspina A, Howell ML, Wang W, DiPoto AC, et al. Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms. Proceedings of the National Academy of Sciences of the United States of America. 2006; 103:19436-41. PMID: 17158796
59. Swingler S, Brichacek B, Jacque JM, Ulich C, Zhou J, Stevenson M. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature. 2003; 424:213-9. PMID: 12853962
60. Jacobsen MC, Thiebaut R, Fisher C, Sefe D, Clapson M, Klein N, et al. Pediatric human immunodeficiency virus infection and circulating IgD+ memory B cells. The Journal of infectious diseases. 2008; 198:481-5. doi: 10.1086/590215 PMID: 18582200
61. Levesque MC, Moody MA, Hwang KK, Marshall DJ, Whitesides JF, Amos JD, et al. Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS medicine. 2009; 6:e1000107. doi: 10.1371/journal.pmed.1000107 PMID: 19582166
62. Abzug MJ, Nachman SA, Muresan P, Handelsman E, Watts DH, Fenton T, et al. Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2013; 56:1488-97.
63. Weinberg A, Song LY, Wilkening CL, Fenton T, Hural J, Louzao R, et al. Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays. J Immunol Methods. 2010; 363:42-50. doi: 10.1016/j.jim.2010.09.032 PMID: 20888337
64. Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, Louzao R, et al. Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin Vaccine Immunol. 2009; 16:1176-86. doi: 10.1128/CVI.00342-08 PMID: 19515870
65. Bull M, Lee D, Stucky J, Chiu YL, Rubin A, Horton H, et al. Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J Immunol Methods. 2007; 322:57-69. PMID: 17382342
66. Bentebibel SE, Lopez S, Obermoser G, Schmitt N, Mueller C, Harrod C, et al. Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Science translational medicine. 2013; 5:176ra32. doi: 10.1126/scitranslmed.3005191 PMID: 23486778
67. Hatano H, Jain V, Hunt PW, Lee TH, Sinclair E, Do TD, et al. Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. The Journal of infectious diseases. 2013; 208:50-6. doi: 10.1093/infdis/jis630 PMID: 23089590
68. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. The Journal of pathology. 2008; 214:231-41. PMID: 18161758
69. Muyanja E, Ssemaganda A, Ngauv P, Cubas R, Perrin H, Srinivasan D, et al. Immune activation alters cellular and humoral responses to yellow fever 17D vaccine. The Journal of clinical investigation. 2014; 124:1. doi: 10.1172/JCI72323 PMID: 24642469
70. Weinberg A, Pahwa S, Oyomopito R, Carey VJ, Zimmer B, Mofenson L, et al. Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2004; 39:107-14. PMID: 15206061
71. Sasaki S, Jaimes MC, Holmes TH, Dekker CL, Mahmood K, Kemble GW, et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. Journal of virology. 2007; 81:215-28. PMID: 17050593
72. Ho J, Moir S, Wang W, Posada JG, Gu W, Rehman MT, et al. Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals. AIDS. 2011; 25:295-302. doi: 10.1097/QAD.0b013e328342328b PMID: 21157297
73. Moir S, Fauci AS. Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals. Immunological reviews. 2013; 254:207-24. doi: 10.1111/imr.12067 PMID: 23772622
74. Antonioli L, Pacher P, Vizi ES, Hasko G. CD39 and CD73 in immunity and inflammation. Trends in molecular medicine. 2013; 19:355-67. doi: 10.1016/j.molmed.2013.03.005 PMID: 23601906
75. Schena F, Volpi S, Faliti CE, Penco F, Santi S, Proietti M, et al. Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity. Cell reports. 2013; 3:1824-31. doi: 10.1016/j.celrep.2013.05.022 PMID: 23770243
76. Chougnet CA, Shearer GM. Regulatory T cells (Treg) and HIV/AIDS: summary of the September 7-8, 2006 workshop. AIDS Res Hum Retroviruses. 2007; 23:945-52. PMID: 17678480
77. Zenclussen AC, Gerlof K, Zenclussen ML, Sollwedel A, Bertoja AZ, Ritter T, et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol. 2005; 166:811-22. PMID: 15743793
78. Richardson K, Weinberg A. Dynamics of regulatory T-cells during pregnancy: effect of HIV infection and correlations with other immune parameters. PloS one. 2011; 6:e28172. doi: 10.1371/journal.pone.0028172 PMID: 22140535
79. Weinberg A, Song LY, Fenton T, Nachman SA, Read JS, Patterson-Bartlett J, et al. T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines. AIDS Res Hum Retroviruses. 2010; 26:51-9. doi: 10.1089/aid.2009.0163 PMID: 20059397
80. Weinberg A, Muresan P, Fenton T, Richardson K, Dominguez T, Bloom A, et al. High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088). Human vaccines & immunotherapeutics. 2013; 9:957-68.
81. Hammitt LL, Bartlett JP, Li S, Rahkola J, Lang N, Janoff EN, et al. Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine. Vaccine. 2009; 27:7359-66. doi: 10.1016/j.vaccine.2009.09.041 PMID: 19800447
82. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, Salimi N, et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106:20365-70. doi: 10.1073/pnas.0911580106 PMID: 19918065
83. Nayak JL, Fitzgerald TF, Richards KA, Yang H, Treanor JJ, Sant AJ. CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine. The Journal of infectious diseases. 2013; 207:297-305. doi: 10.1093/infdis/jis684 PMID: 23148285
84. Pedersen GK, Madhun AS, Breakwell L, Hoschler K, Sjursen H, Pathirana RD, et al. T-helper 1 cells elicited by H5N1 vaccination predict seroprotection. The Journal of infectious diseases. 2012; 206:158-66. doi: 10.1093/infdis/jis330 PMID: 22551811
85. Cooper C, Thorne A, Klein M, Conway B, Boivin G, Haase D, et al. Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults. PloS one. 2011; 6:e17758. doi: 10.1371/journal.pone.0017758 PMID: 21512577
86. El Sahly HM, Davis C, Kotloff K, Meier J, Winokur PL, Wald A, et al. Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial. The Journal of infectious diseases. 2012; 205:703-12. doi: 10.1093/infdis/jir837 PMID: 22275399
87. Lagler H, Grabmeier-Pfistershammer K, Touzeau-Romer V, Tobudic S, Ramharter M, Wenisch J, et al. Immunogenicity and tolerability after two doses of non-adjuvanted, whole-virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals. PloS one. 2012; 7:e36773. doi: 10.1371/journal.pone.0036773 PMID: 22629330